This site is part of the Informa Connect Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC's registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 3099067.

Antibody Engineering & Therapeutics US

Hurry! $600 Savings End In:

  • 00
    Days
  • 00
    Hrs
  • 00
    Mins
  • 00
    Secs
December 13 - 16, 2023
Marriott Marquis San DiegoLive In-Person Event: December 13 - 16, 2023

Katrina Bykova, PhD
Group Leader, Discovery Biology & Pharmacology at Xencor

Profile

Katrina Bykova, PhD, is a Associate Director in the Discovery Biology & Pharmacology department at Xencor, Inc. Her work at Xencor is focused on development of bispecific antibodies that are designed to modulate patient immune system to enhance the anti-tumor response. Prior to joining Xencor Katrina led target discovery efforts and therapeutic programs in the immune-oncology and autoimmunity fields at BMS and Amgen where she worked on T cell modulation and pathways targeting a myeloid component of the tumor microenvironment. Katrina holds a PhD in Pharmacology and Toxicology from University of California.

Agenda Sessions

  • Targeting Multiple Activating Pathways with Natural Killer Cell Engagers

    4:45pm